306 related articles for article (PubMed ID: 10595931)
1. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
[TBL] [Abstract][Full Text] [Related]
2. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
[TBL] [Abstract][Full Text] [Related]
3. Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses.
Rostagno A; Frizzera G; Ylagan L; Kumar A; Ghiso J; Gallo G
Br J Haematol; 2002 Oct; 119(1):62-9. PubMed ID: 12358904
[TBL] [Abstract][Full Text] [Related]
4. Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization.
Picken MM; Frangione B; Barlogie B; Luna M; Gallo G
Am J Pathol; 1989 Apr; 134(4):749-54. PubMed ID: 2495723
[TBL] [Abstract][Full Text] [Related]
5. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
[TBL] [Abstract][Full Text] [Related]
6. Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin kappa light chain deposits. A human disease to study alterations of protein conformation.
Kaplan B; Vidal R; Kumar A; Ghiso J; Frangione B; Gallo G
Clin Exp Immunol; 1997 Dec; 110(3):472-8. PubMed ID: 9409653
[TBL] [Abstract][Full Text] [Related]
7. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
[TBL] [Abstract][Full Text] [Related]
8. Primary structure of a variable region of the V kappa I subgroup (ISE) in light chain deposition disease.
Rocca A; Khamlichi AA; Aucouturier P; Noël LH; Denoroy L; Preud'homme JL; Cogné M
Clin Exp Immunol; 1993 Mar; 91(3):506-9. PubMed ID: 7680298
[TBL] [Abstract][Full Text] [Related]
9. Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.
Colombat M; Mal H; Copie-Bergman C; Diebold J; Damotte D; Callard P; Fournier M; Farcet JP; Stern M; Delfau-Larue MH
Blood; 2008 Sep; 112(5):2004-12. PubMed ID: 18483396
[TBL] [Abstract][Full Text] [Related]
10. Kidney and liver involvement in monoclonal light chain disorders.
Pozzi C; Locatelli F
Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary light chain deposition disease: report of five cases and review of the literature.
Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
[TBL] [Abstract][Full Text] [Related]
12. Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.
Cogné M; Preud'homme JL; Bauwens M; Touchard G; Aucouturier P
J Clin Invest; 1991 Jun; 87(6):2186-90. PubMed ID: 1904072
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.
Buxbaum J
Hematol Oncol Clin North Am; 1992 Apr; 6(2):323-46. PubMed ID: 1582976
[TBL] [Abstract][Full Text] [Related]
14. Structural peculiarities of a truncated V kappa III immunoglobulin light chain in myeloma with light chain deposition disease.
Decourt C; Cogné M; Rocca A
Clin Exp Immunol; 1996 Nov; 106(2):357-61. PubMed ID: 8918585
[TBL] [Abstract][Full Text] [Related]
15. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
Kaplan B; Livneh A; Gallo G
Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
[TBL] [Abstract][Full Text] [Related]
16. A case of isolated light chain deposition disease in the duodenum.
Kim HJ; Park E; Lee TJ; Do JH; Cha YJ; Lee SJ
J Korean Med Sci; 2012 Feb; 27(2):207-10. PubMed ID: 22323870
[TBL] [Abstract][Full Text] [Related]
17. Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.
Khamlichi AA; Aucouturier P; Silvain C; Bauwens M; Touchard G; Preud'homme JL; Nau F; Cogné M
Clin Exp Immunol; 1992 Jan; 87(1):122-6. PubMed ID: 1733627
[TBL] [Abstract][Full Text] [Related]
18. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
Buxbaum J; Gallo G
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1235-48. PubMed ID: 10626147
[TBL] [Abstract][Full Text] [Related]
19. Infiltrative nonamyloidotic monoclonal immunoglobulin light chain cardiomyopathy: an underappreciated manifestation of plasma cell dyscrasias.
Buxbaum JN; Genega EM; Lazowski P; Kumar A; Tunick PA; Kronzon I; Gallo GR
Cardiology; 2000; 93(4):220-8. PubMed ID: 11025347
[TBL] [Abstract][Full Text] [Related]
20. Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach.
Sivaraj D; Green MM; Ciftci AM; Zahid MF; Johns AA; Ross M; Gasparetto C
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e95-e100. PubMed ID: 27101986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
